HSE warns pharma firms about payments to doctors
The HSE wants pharmaceutical companies to name those in receipt of payments for travel, sponsorship, medical education, grants and other activities
The Health Service Executive (HSE) has warned that it may stop buying medicines from pharmaceutical companies who do not name the individual doctors and healthcare organisations in receipt of multimillion euro payments from them.
The HSE wants pharmaceutical companies to name those in receipt of payments for travel, sponsorship, medical education, grants, medical and nursing posts, and various other unknown activities.
Last November, this newspaper revealed that hospitals were unable to account for millions of...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
More than 400 children taken into state care in first half of 2020
There are now almost 6,000 children in care in Ireland
Susan O’Keeffe: Missed cancer diagnoses hint at true toll of fight against Covid-19
Stark figures act as a flag for every other medical condition that has been ignored, downplayed, downgraded and sidestepped since the pandemic was declared
De Gascun: negative result not passport to ignore advice
The director of the National Virus Reference Laboratory warns coronavirus may not show up on a test for one or two days if people have already caught it from their travels
HSE spent €740,000 refurbishing headquarters over past three years
Leasing alternative office space to that at Dr Steevens’ Hospital would cost ‘between €4.5 million and €9.5 million a year’